A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding

Background: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hy...

Full description

Bibliographic Details
Main Authors: T Justin Clark, Lee J Middleton, Natalie AM Cooper, Lavanya Diwakar, Elaine Denny, Paul Smith, Laura Gennard, Lynda Stobert, Tracy E Roberts, Versha Cheed, Tracey Bingham, Sue Jowett, Elizabeth Brettell, Mary Connor, Sian E Jones, Jane P Daniels
Format: Article
Language:English
Published: NIHR Journals Library 2015-07-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta19610
id doaj-8ae1ecd4aed44841b0f111717911d90e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author T Justin Clark
Lee J Middleton
Natalie AM Cooper
Lavanya Diwakar
Elaine Denny
Paul Smith
Laura Gennard
Lynda Stobert
Tracy E Roberts
Versha Cheed
Tracey Bingham
Sue Jowett
Elizabeth Brettell
Mary Connor
Sian E Jones
Jane P Daniels
spellingShingle T Justin Clark
Lee J Middleton
Natalie AM Cooper
Lavanya Diwakar
Elaine Denny
Paul Smith
Laura Gennard
Lynda Stobert
Tracy E Roberts
Versha Cheed
Tracey Bingham
Sue Jowett
Elizabeth Brettell
Mary Connor
Sian E Jones
Jane P Daniels
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
Health Technology Assessment
author_facet T Justin Clark
Lee J Middleton
Natalie AM Cooper
Lavanya Diwakar
Elaine Denny
Paul Smith
Laura Gennard
Lynda Stobert
Tracy E Roberts
Versha Cheed
Tracey Bingham
Sue Jowett
Elizabeth Brettell
Mary Connor
Sian E Jones
Jane P Daniels
author_sort T Justin Clark
title A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
title_short A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
title_full A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
title_fullStr A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
title_full_unstemmed A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
title_sort randomised controlled trial of outpatient versus inpatient polyp treatment (opt) for abnormal uterine bleeding
publisher NIHR Journals Library
series Health Technology Assessment
issn 1366-5278
2046-4924
publishDate 2015-07-01
description Background: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hypothesis that in women with abnormal uterine bleeding (AUB) associated with benign uterine polyp(s), outpatient polyp treatment achieved as good, or no more than 25% worse, alleviation of bleeding symptoms at 6 months compared with standard inpatient treatment. The hypothesis that response to uterine polyp treatment differed according to the pattern of AUB, menopausal status and longer-term follow-up was tested. The cost-effectiveness and acceptability of outpatient polypectomy was examined. Design: A multicentre, non-inferiority, randomised controlled trial, incorporating a cost-effectiveness analysis and supplemented by a parallel patient preference study. Patient acceptability was evaluated by interview in a qualitative study. Setting: Outpatient hysteroscopy clinics and inpatient gynaecology departments within UK NHS hospitals. Participants: Women with AUB – defined as heavy menstrual bleeding (formerly known as menorrhagia) (HMB), intermenstrual bleeding or postmenopausal bleeding – and hysteroscopically diagnosed uterine polyps. Interventions: We randomly assigned 507 women, using a minimisation algorithm, to outpatient polypectomy compared with conventional inpatient polypectomy as a day case in hospital under general anaesthesia. Main outcome measures: The primary outcome was successful treatment at 6 months, determined by the woman’s assessment of her bleeding. Secondary outcomes included quality of life, procedure feasibility, acceptability and cost per quality-adjusted life-year (QALY) gained. Results: At 6 months, 73% (166/228) of women who underwent outpatient polypectomy were successfully treated compared with 80% (168/211) following inpatient polypectomy [relative risk (RR) 0.91, 95% confidence interval (CI) 0.82 to 1.02]. The lower end of the CIs showed that outpatient polypectomy was at most 18% worse, in relative terms, than inpatient treatment, within the 25% margin of non-inferiority set at the outset of the study. By 1 and 2 years the corresponding proportions were similar producing RRs close to unity. There was no evidence that the treatment effect differed according to any of the predefined subgroups when treatments by variable interaction parameters were examined. Failure to completely remove polyps was higher (19% vs. 7%; RR 2.5, 95% CI 1.5 to 4.1) with outpatient polypectomy. Procedure acceptability was reduced with outpatient compared with inpatient polyp treatment (83% vs. 92%; RR 0.90, 95% CI 0.84 to 0.97). There were no significant differences in quality of life. The incremental cost-effectiveness ratios at 6 and 12 months for inpatient treatment were £1,099,167 and £668,800 per additional QALY, respectively. Conclusions: When treating women with AUB associated with uterine polyps, outpatient polypectomy was non-inferior to inpatient polypectomy at 6 and 12 months, and relatively cost-effective. However, patients need to be aware that failure to remove a polyp is more likely with outpatient polypectomy and procedure acceptability lower. Trial registration: Current Controlled Trials ISRCTN 65868569. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 61. See the NIHR Journals Library website for further project information.
url https://doi.org/10.3310/hta19610
work_keys_str_mv AT tjustinclark arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT leejmiddleton arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT natalieamcooper arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lavanyadiwakar arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT elainedenny arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT paulsmith arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lauragennard arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lyndastobert arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT tracyeroberts arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT vershacheed arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT traceybingham arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT suejowett arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT elizabethbrettell arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT maryconnor arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT sianejones arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT janepdaniels arandomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT tjustinclark randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT leejmiddleton randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT natalieamcooper randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lavanyadiwakar randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT elainedenny randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT paulsmith randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lauragennard randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT lyndastobert randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT tracyeroberts randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT vershacheed randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT traceybingham randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT suejowett randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT elizabethbrettell randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT maryconnor randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT sianejones randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
AT janepdaniels randomisedcontrolledtrialofoutpatientversusinpatientpolyptreatmentoptforabnormaluterinebleeding
_version_ 1724834158703804416
spelling doaj-8ae1ecd4aed44841b0f111717911d90e2020-11-25T02:29:16ZengNIHR Journals LibraryHealth Technology Assessment1366-52782046-49242015-07-01196110.3310/hta1961006/404/84A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleedingT Justin Clark0Lee J Middleton1Natalie AM Cooper2Lavanya Diwakar3Elaine Denny4Paul Smith5Laura Gennard6Lynda Stobert7Tracy E Roberts8Versha Cheed9Tracey Bingham10Sue Jowett11Elizabeth Brettell12Mary Connor13Sian E Jones14Jane P Daniels15Birmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKWomen’s Health Research Unit, The Blizard Institute, Queen Mary University of London, London, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKCentre for Health and Social Care Research, Faculty of Health, Birmingham City University, Edgbaston, Birmingham, UKBirmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKCentre for Health and Social Care Research, Faculty of Health, Birmingham City University, Edgbaston, Birmingham, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKBirmingham Women’s Hospital NHS Foundation Trust, Edgbaston, Birmingham, UKHealth Economics Unit, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBirmingham Clinical Trials Unit, University of Birmingham, Birmingham, UKJessop Wing, Sheffield Teaching Hospitals NHS Trust, Sheffield, UKBradford Teaching Hospitals NHS Foundation Trust, Bradford, UKSchool of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKBackground: Uterine polyps cause abnormal bleeding in women and conventional practice is to remove them in hospital under general anaesthetic. Advances in technology make it possible to perform polypectomy in an outpatient setting, yet evidence of effectiveness is limited. Objectives: To test the hypothesis that in women with abnormal uterine bleeding (AUB) associated with benign uterine polyp(s), outpatient polyp treatment achieved as good, or no more than 25% worse, alleviation of bleeding symptoms at 6 months compared with standard inpatient treatment. The hypothesis that response to uterine polyp treatment differed according to the pattern of AUB, menopausal status and longer-term follow-up was tested. The cost-effectiveness and acceptability of outpatient polypectomy was examined. Design: A multicentre, non-inferiority, randomised controlled trial, incorporating a cost-effectiveness analysis and supplemented by a parallel patient preference study. Patient acceptability was evaluated by interview in a qualitative study. Setting: Outpatient hysteroscopy clinics and inpatient gynaecology departments within UK NHS hospitals. Participants: Women with AUB – defined as heavy menstrual bleeding (formerly known as menorrhagia) (HMB), intermenstrual bleeding or postmenopausal bleeding – and hysteroscopically diagnosed uterine polyps. Interventions: We randomly assigned 507 women, using a minimisation algorithm, to outpatient polypectomy compared with conventional inpatient polypectomy as a day case in hospital under general anaesthesia. Main outcome measures: The primary outcome was successful treatment at 6 months, determined by the woman’s assessment of her bleeding. Secondary outcomes included quality of life, procedure feasibility, acceptability and cost per quality-adjusted life-year (QALY) gained. Results: At 6 months, 73% (166/228) of women who underwent outpatient polypectomy were successfully treated compared with 80% (168/211) following inpatient polypectomy [relative risk (RR) 0.91, 95% confidence interval (CI) 0.82 to 1.02]. The lower end of the CIs showed that outpatient polypectomy was at most 18% worse, in relative terms, than inpatient treatment, within the 25% margin of non-inferiority set at the outset of the study. By 1 and 2 years the corresponding proportions were similar producing RRs close to unity. There was no evidence that the treatment effect differed according to any of the predefined subgroups when treatments by variable interaction parameters were examined. Failure to completely remove polyps was higher (19% vs. 7%; RR 2.5, 95% CI 1.5 to 4.1) with outpatient polypectomy. Procedure acceptability was reduced with outpatient compared with inpatient polyp treatment (83% vs. 92%; RR 0.90, 95% CI 0.84 to 0.97). There were no significant differences in quality of life. The incremental cost-effectiveness ratios at 6 and 12 months for inpatient treatment were £1,099,167 and £668,800 per additional QALY, respectively. Conclusions: When treating women with AUB associated with uterine polyps, outpatient polypectomy was non-inferior to inpatient polypectomy at 6 and 12 months, and relatively cost-effective. However, patients need to be aware that failure to remove a polyp is more likely with outpatient polypectomy and procedure acceptability lower. Trial registration: Current Controlled Trials ISRCTN 65868569. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 19, No. 61. See the NIHR Journals Library website for further project information.https://doi.org/10.3310/hta19610